 |
 |
 |
 |
- No clinically relevant differences between memantine- and placebo-treated
groups were observed in:
— Adverse event profile
— Vital signs values
— Laboratory parameters
— ECG values
- Memantine at a dosage of 20 mg/d
— Exhibits a safety profile similar to that of placebo
— Is well-tolerated and safe for the treatment of patients with AD
